Covax Pharmaceuticals (688136.SH) shareholder Koyi Pharmaceuticals plans to inquire about transferring a 3% stake.

Securities Times News, Ke Xing Pharmaceutical (688136.SH) released a shareholder inquiry transfer plan. The shareholder participating in the pre-IPO shareholder inquiry transfer of Ke Xing Pharmaceutical is Shenzhen Keyi Pharmaceutical Holdings Co., Ltd. The total number of shares to be transferred by the seller is 6.0377 million shares, accounting for 3.00% of the total share capital of the company.